Observational studyBritish journal of haematology2026

Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.

Noriyoshi Iriyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.